[Effect of cisplatinum (CDDP) and combined chemotherapy with CDDP on peripheral blood lymphocyte natural killer (NK) activity].
Baba
M
M
Dept. of Clinical Pathology, Nippon Medical School.
Shibuya
M
M
Iizuka
K
K
Sakai
S
S
Hirata
S
S
Ohtsuka
M
M
Aoyama
A
A
Niitani
H
H
Koizumi
K
K
Shohji
T
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000276:immunology; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology; D015376:Nimustine / Q000008:administration & dosage; D010844:Picibanil / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage
D015376:Nimustine; D010844:Picibanil; D002945:Cisplatin; D014751:Vindesine